The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
How do we know AS is no good as a CEO?
We have zero info really, on how the company is financially run.
My beef (for a long time) was to me, (I stress the "me") the misleading info he has released on interviews. However I am also aware that he has little choice other than to paint a partial picture of exaggerating the positive and down playing or ignoring the negative aspects. The rounder picture is only revealed either way after the event, or through more intrusive questioning. As a results all of those Paul Hill Interviews to me looked scripted. Its why AVCT choose what questions are allowed in Q&A sections etc etc. But that is part of the job and does not reflect AVCT financial acumen (or not).
What if ....
What if the DX deals were actually a recognition of the opportunity of this fragmented huge market and these companies were/are undervalued and all they needed was extra resource and funding to get them to the next level? This would take capital investment, and added resources which AVCT have provided. Then all of a sudden the DX deals would look pretty savvy. An alternative might be the silence on this might be to have kept the valuation low, because the time for DX to be worth as a spin off, a reasonable amount was not going to come in time before more funding and AS hinted/mentioned/said/ that AVCT was valued too highly given the stage of where it was in its development.
Which gets us to the raise as the other contentious issue of his stewardship.
Some here did not see it coming but plenty did and I think so did the market. What I think took many more by surprise was the low price . This suggests that maybe AVCT were not in full control at that stage to be able to dictate terms in any meaningful way. I imagine this will not be the last raise (assuming there is no TO.) Therefore these funds may well be tapped again if they have kept their stock in the future, and they are building their stakes at effectively discounted prices. (The next raise can only come after yet more successful results). So they have a further de-risked proposition at, as I say, a discount to the market. That, if it was part of the deal, means that AVCT are looking 18-24 months ahead and would make sense of the don't worry about the funding remark, as he was not talking about this one but ultimately securing the future to keep AVCT independent to return max shareholder value.
I don't know if this musing has any validity, but as an alternative scenario it at least highlights our complete ignorance of actually what goes on behind the scenes and maybe we should not always rush and jump to conclusions when we should rather, admit our lack of knowledge a bout these matters.
On the other hand the BOD might well be, not up to the job......
Written with AI. Assistance lol
Sunday double time Winne ?
Yeah thats right watching.... what's your excuse?
If you believe I am paid then why don't you just filter me? why read anything I say? What reason could you give to monitor this BB 7 days a week.
It can't be what I post because I post a whole range of views. From TA (up or down as I think it will go), to potential explanations of the events as they unfold, so its not content.
So what, as you would say, sad, miserable boring life do you have that your only comment is to invent and make stuff up? Its nothing to do with AVCt when you religiously keep up this silly pointless and childish posts with absolutely no thought at all in what you are saying.
I guess you don't yet have the maturity to think very far ahead. Well hopefully that will come in time.
Winne you just keep going over the same sh#t. Move on !
Wyndrum your intellect, well written thoughtful posts leave posters like Watching , Ice , NY and Timster behind. They do not have the intellect to see there just may be another side to the current situation. I’m sure they have all gambled more than they really can afford to lose on this company and therefore have only blind hope and desperation that it will come good. Hence as soon as the share price shows a glimmer of heading North all we hear about is £120 by morning, size buyers now stepping up blah blah blah.
People like Yeboah who when the share price was £1.60 were gobble gobble gobble have now disappeared. Amazing !
Sheppy simple question for you, with the science presented so far, why would the FDA not approve AVA6000? What in the evidence presented so far that is a stumbling block scientifically? I await an answer with bated breath. Also where the premium you are minted….. 😉
Wyndrone and intellect in the same sentence well that's a strange phenomenon but then again it's written by the board fantasist. Where are you today sheppy Galapagos riding a tortoise?
I do not dispute the science on the information provided to us however the caveat is it is in a relatively small sample size and not peer reviewed. Efficacy is certainly not proven and that could lead to a non FDA approval of course.
The problem I have is the commercial acumen of the people trying to commercialise the opportunity.
AS repeatedly misses deadlines , is economical with the truth in his comments or perhaps a kinder way of saying it is he makes open/pointed comments and hopes you interpret them to mean a positive outcome. Maybe that’s very clever actually I don’t know to be honest.
Finally we have all had our say on the recent incorrect RNS but that error was truly unforgivable. It worries me that if this is an indication of their competence then FDA approval is certainly not a cert.
As far as my wealth goes Ice I’m sat on the terrace in my villa in Elviria near Marbella looking at Gibraltar in the distance. If you do not believe me I truly could not care less as it won’t change the fact that that is where I am sat.
I’m not saying AVA6000 doesn’t work but we could be surprised at the amount of time and money it takes to determine optimum target patients and dosing regime. Meanwhile a lot of money is going into other forms of cancer treatment.
You all need to do some research on how much FDA oncology drugs are worth then re-evaluate the micro thinking, that further potential dilution will have any great impact on the investment case here. The Mkt cap here is only 175 million odd. Oncology drugs go into the billions not to mention full validation of platform. The science is exceptional, actually they say clearly proof of concept has been achieved. The sample size while small at the moment has been backed by 10+ biopsy data and nothing in the science says we won’t see efficacy in high fap dox sensitive tumours. So sheppy nothing in the science then just small sample size and yet to prove efficacy on paper how very boring 🥱. An FDA approval decision will happen inevitably. If positive that will be the catalyst for success here.
Three clowns in a line on a thread ! Do I win a prize 😄
Sheppy's become wyndrone but with extra powers. Have you found the million you lost yet sheppy ?
The shortin* fud team seen to uneasy today. lol.its Burn time !
The thing is Ice, when?
|You keep saying Micro this Macro that, as though somehow that is an argument that trumps all others, but other small oncology companies are as you say, being bought out, so why hasn't AVCT?
The science worked clearly (from our pov) after cohort 3, or 4 to be absolutely sure. Why then another 3 to go up to 7? wasn't it only to emphasize how fantastic it was?
Is that what you believe? Or do you accept that after dose 4 it was not unequivocal that it worked and that more dosing was required?
Because it seems to me, if it "works" in the way that you are so absolutely convinced by and its just a matter of time, then AVCT should have been bought out already but if more proof were needed then it means clearly, the data was not as one sided as we all were led to believe?
Which one is it?
Says Watching the biggest clown of the lot!
I’m in at 68 p how good am I and how clever am I? Oh yes just realised the share price is 43 p and I’m losing money. Mmm
A real clown!
Good luck to you sheppy / I’m in Dubai currently by a pool looking at the Burj Khalifa & I’m travelling round the south of France for a month in a couple of weeks time - no permanent oversea residences for me but I’m happy staying in Avacta! 🥂 and certainly hope the shorters here get burned next week GL
Some hypothetical scenarios below.
Maybe Avacta are not for sale this raise was to protect any hostile takeover attempts.
Alternatively a price has already been agreed on condition of positive results in phase 2. That would explain why they don’t give a toss about current share price. If they have provisionally agreed a price on positive data, today’s price is irrelevant.
They are also building a platform of chemo drugs, I’m sure they probably could have rushed AVA6000 after cohort 4 however the fact they didn’t find an MTD and got valuable information will help the clinical process of other drug candidates AVA3996.
AVA6000 will get approved when it’s ready to get approved, you might be beholden to a timeline, I am happy to wait for the inevitable conclusion no matter how long it takes. (it will conclude and a decision will be made one way or another as data emerges) The prize on offer of approval of AVA6000 will be worth the wait in the long run, if you believe it will happen.
"They are also building a platform of chemo drugs, I’m sure they probably could have rushed AVA6000 after cohort 4 however the fact they didn’t find an MTD and got valuable information will help the clinical process of other drug candidates AVA3996."
Your sure.. probably... yet no other pahrma can see it or has seen it yet, although AVCT have moved to London to be next door to BP and all the other "likes" from other players in the field, and the science day and the posters that have been displayed and the RNS's (which always move the SP so someone is reading, but not apparently people as smart as you to figure it out.
Buth this was the best one...."Maybe Avacta are not for sale this raise was to protect any hostile takeover attempts."
Ha ha ha, My house is not for sale so I am going to reduce the price by 50% to put people off from trying to buy it.....
Do you not, when you are writing out your reply realise how desperate it sounds?
Wyndrum they are not ‘right bright’ to use a Yorkshire expression!
Are you on Avacta board meetings? You don’t have a clue what is going on??? You make huge hypothetical assumptions everyday, what contact has been made by BP we don’t have a clue what discussions have been done etc also Avacta obviously don’t care about the share price they were wanting institutional representation at all costs why is that? Maybe they wanted to protect any hostile takeover at the voting stage……. You really are an idiot sometimes, I still don’t think you are invested as well tbh.
I think you are the idiot Ice
Thanks Sheppy I feel flattered a multi millionaire would take time to call me an idiot on an investment forum. Truly privileged!! 😊😊💯
Did you not call Wyndrum an idiot? You really are something else
"You really are an idiot sometimes, "
Ice, really, Its you that are so sure about everything. I am forever saying we don't know Jack.
What i try to see if is there any cause and effect.
I see more cohorts and dosing which AVCT says were an unexpected surprise, delaying the trail but about 12-15 months. This then caused another raise.
I see thanks to hurst, every tom dick and harry being bought out for billions on what at face value seems a tiny fraction of AVCT's value, so i come to the conclusion that BP are not interested (for whatever reason), and in the meantime the 3 raises that have come in at 120p, 95p and now 50p causing ever more dilution and capital destruction as a company that is running a trial that has so far not gone to their plan.
You on the other hand see 3 years of SP decline as micro BS and keep saying when FDA approval comes etc etc as though its nailed on.
If it were already done, it would already be approved.
Yet I am the short term gambler and you are the long term.... (use any adjective that comes to mind to make you feel better.
(And not for nothing but my last purchase of last week is up 10%, you may think thats peanuts but its a start, let me know when you get to breakeven, admittedly my purchase was based on the voodoo of charts, but who cares. I could have bought a load at 50p instead, although at the time I said I wouldn't due to the voodoo thing again.)
Sheppy aka wynbore yes 68p. That will be £6.80. Plus in a few years. Your are such a muppet.